Intrauterine Insemination Devices Market revenue to hit USD 62 Billion by 2035, says Research Nester
September 25, 2023 05:30 ET
|
Research Nester
New York, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The global intrauterine insemination devices market size is expected to expand at ~4% CAGR from 2023 to 2035. The market is anticipated to garner a...
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
August 24, 2023 10:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
August 22, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
[Latest] Global Fixed Mobile Convergence Market Size/Share Worth USD 11956.76 Billion by 2032 at a 13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 10, 2023 14:20 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Fixed Mobile Convergence Market Size, Trends and Insights By Network Convergence...
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
July 25, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
July 20, 2023 07:11 ET
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Joins Webull Corporate Connect
June 29, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
June 27, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Foot Orthotic Insoles Market Size to Surpass USD 6.26 Billion in 2030, exhibiting a CAGR of 6.8%
June 22, 2023 07:34 ET
|
Fortune Business Insights
Pune, India, June 22, 2023 (GLOBE NEWSWIRE) -- The global foot orthotic insoles market size was USD 3.62 billion in 2022. The market is anticipated to expand from USD 3.96 billion in 2023 to USD...
CytoSorbents Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial Without Modifications Following Second Scheduled Safety Review
June 15, 2023 07:00 ET
|
CytoSorbents
PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...